Pablo Ortiz Betes

One Way Liver SL designs and develops diagnostic solutions for liver conditions. It designs and develops of non-invasive diagnostic solutions for hepatic conditions, such as fatty liver disease and non-alcoholic steatohepatitis. The firm also provides research and clinical testing services to clients in the pharmaceutical and biomedical product industries. The company was founded by José Maria Mato de la Paz in 2002 and is headquartered in Derio, Spain.

Digna Biotech is a holding company which provides biomedical dsicovery, research, development, and clinical testing services to clients in the pharmaceutical sector. Its pipeline consists of products for the treatment of sclerodermia, keratosis, multiple sclerosis, corneal ulcers, porphyria, and acute liver failure. The company was founded on February 23, 2003 and is headquartered in Pamplona, Spain.

ProRetina Therapeutics SL develops drugs for the treatment of retinal conditions. Its pipeline includes PRO-001 used for the treatment of retinitis pigmentosa and PRO-015 is a gene vector that codes the human proinsulin gene indicated for Retinitis Pigmentosa. The company was founded by Stuart Medina in 2007 and is headquartered in Noain, Spain.